Tokyo Tape
Sign in
← Sophia Holdings

Quarterly report · Q2

6942.TEDINET S100PMKS
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥4.9bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥11.8bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥5.5bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥210m2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥343m2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥203m2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥889m2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥339m2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥79m2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥339m2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥3m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥613m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥249m2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥3m2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥249m2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥7.7bnat 2022-09-30Cons.Assets
Total assets¥8.6bnat 2022-03-31Cons.Assets
Total assets¥8.3bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥5.7bnat 2022-09-30Cons.Liabilities
Total liabilities¥6.6bnat 2022-03-31Cons.Liabilities
Net assets / equity¥2.0bnat 2022-09-30Cons.Net assets
Net assets / equity¥2.0bnat 2022-03-31Cons.Net assets
Net assets / equity¥1.6bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥2.0bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥2.3bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥2.0bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.3bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥2.0bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥2.1bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥45m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥291m2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥31m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥151m2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥48m2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥371m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥696m2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥326m2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥1.142022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-32.712022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥228.112021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥92.512021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥40.872021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio26.2%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio23.3%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio19.7%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 37
SegmentItemPeriodValue
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥3.3bn
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥3.3bn
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥5m
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥116m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥752m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥746m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥6m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥70m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥868m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥867m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥1m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥47m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥5.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥4.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥12m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥233m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-09-30−¥103,000
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥3.5bn
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥3.5bn
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥5m
jpcrp040300-q2r_E01978-000Dispensing Pharmacy And Related Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥173m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥591m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥582m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥8m
jpcrp040300-q2r_E01978-000Internet Related Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥51m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥1.5bn
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥1.5bn
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥12m
jpcrp040300-q2r_E01978-000Telecommunications Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥170m
—segment totalrevenue2021-04-01 → 2021-09-30¥5.5bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥5.5bn
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥26m
—segment totalsegment profit2021-04-01 → 2021-09-30¥395m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥5.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥5.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥26m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥395m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 530
ItemContextValueUnit
Cost of salesPrior1YTDDuration3613035000JPY
Cost of salesCurrentYTDDuration3172446000JPY
Gross profitPrior1YTDDuration1905859000JPY
Gross profitCurrentYTDDuration1775220000JPY
Selling general and administrative expensesPrior1YTDDuration1562644000JPY
Selling general and administrative expensesCurrentYTDDuration1564734000JPY
Operating incomePrior1YTDDuration343215000JPY
Operating incomeCurrentYTDDuration210485000JPY
Interest income noiPrior1YTDDuration137000JPY
Interest income noiCurrentYTDDuration133000JPY
Dividends income noiPrior1YTDDuration6000JPY
Dividends income noiCurrentYTDDuration4000JPY
Reversal of allowance for doubtful accounts noiPrior1YTDDuration1492000JPY
Reversal of allowance for doubtful accounts noiCurrentYTDDuration1404000JPY
Subsidy income noiPrior1YTDDuration1721000JPY
Subsidy income noiCurrentYTDDuration4335000JPY
Company houses rent income noiPrior1YTDDuration2076000JPY
Company houses rent income noiCurrentYTDDuration3061000JPY
Other noiPrior1YTDDuration6039000JPY
Other noiCurrentYTDDuration5431000JPY
Non operating incomePrior1YTDDuration11473000JPY
Non operating incomeCurrentYTDDuration14370000JPY
Interest expenses noePrior1YTDDuration15106000JPY
Interest expenses noeCurrentYTDDuration12112000JPY
Commission fee for loans payable noePrior1YTDDuration30000JPY
Commission fee for loans payable noeCurrentYTDDuration－JPY
Foreign exchange losses noePrior1YTDDuration79000JPY
Foreign exchange losses noeCurrentYTDDuration－JPY
Loss on sales of crypto assets noePrior1YTDDuration－JPY
Loss on sales of crypto assets noeCurrentYTDDuration4510000JPY
Other noePrior1YTDDuration829000JPY
Other noeCurrentYTDDuration5719000JPY
Non operating expensesPrior1YTDDuration16045000JPY
Non operating expensesCurrentYTDDuration22342000JPY
Ordinary incomePrior1YTDDuration338643000JPY
Ordinary incomeCurrentYTDDuration202513000JPY
Gain on transfer of business eiPrior1YTDDuration5737000JPY
Gain on transfer of business eiCurrentYTDDuration－JPY
Other eiPrior1YTDDuration59000JPY
Other eiCurrentYTDDuration－JPY
Extraordinary incomePrior1YTDDuration5797000JPY
Extraordinary incomeCurrentYTDDuration－JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration79000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration284000JPY
Loss on reversal of foreign currency translation adjustments elPrior1YTDDuration5749000JPY
Loss on reversal of foreign currency translation adjustments elCurrentYTDDuration－JPY
Special survey costs etc elPrior1YTDDuration－JPY
Special survey costs etc elCurrentYTDDuration122916000JPY
Extraordinary lossPrior1YTDDuration5829000JPY
Extraordinary lossCurrentYTDDuration123200000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass